Psoriatic Arthritis

Top Story

Direct-to-consumer genetic testing not ready for prime time in rheumatology

Direct-to-consumer genetic testing not ready for prime time in rheumatology
January 18, 2019
In the Journals

Calprotectin levels predicts relapse in patients with RA, PsA treated with TNF inhibitors

January 9, 2019
Baseline calprotectin serum levels independently predict disease relapse in patients with rheumatoid arthritis and psoriatic arthritis who have achieved remission or low…
In the Journals

Abatacept improves patient-reported outcomes in psoriatic arthritis

December 18, 2018
Weekly doses of abatacept 125 mg for 24 weeks improved patient-reported outcomes in psoriatic arthritis, with better results among patients with elevated C-reactive…
Meeting News

Phase 3 data support etanercept monotherapy for PsA

December 13, 2018
CHICAGO — Phase 3 data from the SEAM-PsA study presented at the ACR/ARHP 2018 Annual Meeting showed that etanercept alone or in combination with methotrexate was…
More Headlines »

Updates in PsA and SpA: Optimizing Care Among the Latest Advances

This activity is supported by an educational grant from Lilly.

Chronic inflammatory diseases, such as psoriatic arthritis (PsA) and ankylosing spondylitis (AS), represent a group of…
More »
Meeting News Coverage

VIDEO: Use of checkpoint inhibitors has advanced the treatment of cancer

August 5, 2016
More »

Ace the Case: A 56-year-old Caucasian Female with a 5-year History of Seropositive Rheumatoid Arthritis

There is no commercial support for this activity.

This “Ace the Case” study will discuss treatment options in patients with rheumatoid arthritis who have had an…
More »